Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02984384 · ClinicalTrials.gov registry record · Phase 3
PREVENTion of Clot in Orthopaedic Trauma
A Phase 3 study, sponsored by Major Extremity Trauma Research Consortium.
- Completed
- Registry status
- Phase 3
- Development phase
- 12,424
- Enrollment target
NCT02984384: Completed Phase 3 study, sponsored by Major Extremity Trauma Research Consortium.
NCT02984384 is a Phase 3 study that has completed, run by Major Extremity Trauma Research Consortium. The registered enrollment target is 12,424 participants, above the 771-participant average among 15,282 other Phase 3 trials with a reported enrollment target (1511% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02984384, a Phase 3 study, has completed, sponsored by Major Extremity Trauma Research Consortium.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 12,424 participants
- Enrollment target
Study Summary
The purpose of this study is to compare aspirin versus low-molecular weight heparin (LMWH) (Enoxaparin) as a thromboprophylaxis in patients who sustain a fracture.
Primary Outcome
Death from any cause
Interventions
- DRUG Acetylsalicylic acid
- DRUG Low Molecular Weight Heparin (LMWH)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,424 participants |
| Start Date | 2017-04-24 |
| Est. Completion | 2022-02-18 |
| Phase | Phase 3 |
What the finished NCT02984384 record still lists
NCT02984384 is an interventional study that assigns participants to a tested intervention. Its 12,424 participants enrollment target places it among the larger protocols in the corpus, above the 771-participant average among 15,282 other Phase 3 trials with a reported enrollment target (1511% higher).
The record links to 0 conditions, and to 2 interventions - of which Acetylsalicylic acid is the first listed.
NCT02984384 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02984384 about?
NCT02984384 is a clinical study titled "PREVENTion of Clot in Orthopaedic Trauma". The purpose of this study is to compare aspirin versus low-molecular weight heparin (LMWH) (Enoxaparin) as a thromboprophylaxis in patients who sustain a fracture.
What is the current status of trial NCT02984384?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 12,424 participants. The study started on 2017-04-24. Estimated completion is 2022-02-18.
What interventions are being tested in trial NCT02984384?
The interventions under investigation include: Acetylsalicylic acid (DRUG), Low Molecular Weight Heparin (LMWH) (DRUG).
Who is sponsoring clinical trial NCT02984384?
This trial is sponsored by Major Extremity Trauma Research Consortium, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02984384's enrollment target sits among peer trials
12,424 20th of 2000 higher than 1,981 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04888832 · 12,500 participants · NA
The Effect of Work Requirements in SNAP in Virginia
- NCT05452941 · 12,500 participants
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
- NCT07069556 · 12,500 participants
ColoSense Post-Approval Study
- NCT07037433 · 12,800 participants · Phase 3
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI